Prostate Cancer Recruiting Phase 2 / 3 Trials for DB01248 (Docetaxel)

Also known as: Prostatic Cancer / Prostatic neoplasms malignant / Carcinoma Prostate / Cancer Of Prostate / Malignant Neoplasm of Prostate / Prostate Cancers / Prostate carcinoma / Carcinoma of the prostate / Cancer, Prostate / Carcinoma of prostate / Prostatic carcinoma / Carcinoma prostatic / Ca prostate / Prostate cancer NOS

IndicationStatusPhase
DBCOND0062462 (Prostate Cancer)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00268476STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled TrialTreatment